Acadian Asset Management LLC / UTHR
Acadian Asset Management LLC’s United Therapeutics Corp Del Position
Does Acadian Asset Management LLC own United Therapeutics Corp Del (UTHR)? Yes — 300.2K shares worth $178M (+0.25% of its 13F portfolio) as of Q1 2026, up from 200.5K shares the prior filed quarter.
Position Value
$178M
Q1 2026
Shares
300.2K
% of Portfolio
+0.25%
Quarters Held
29
currently held
Position History UTHR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 300.2K | $178M | +0.25% |
| Q4 2025 | 200.5K | $98M | +0.16% |
| Q3 2025 | 139.9K | $59M | +0.10% |
| Q2 2025 | 206.0K | $59M | +0.12% |
| Q1 2025 | 179.2K | $55M | +0.16% |
| Q4 2024 | 10.2K | $4M | +0.01% |
| Q3 2024 | 13.6K | $5M | +0.02% |
| Q2 2024 | 22.6K | $7M | +0.02% |
| Q1 2024 | 112.0K | $26M | +0.09% |
| Q4 2023 | 31.5K | $7M | +0.03% |
| Q3 2023 | 49.2K | $11M | +0.05% |
| Q2 2023 | 80.4K | $18M | +0.07% |
| Q1 2023 | 159.4K | $36M | +0.16% |
| Q4 2022 | 55.0K | $15M | +0.08% |
| Q3 2022 | 97.1K | $20M | +0.11% |
| Q2 2022 | 110.7K | $26M | +0.13% |
| Q1 2022 | 272.2K | $49M | +0.20% |
| Q4 2021 | 346.7K | $75M | +0.28% |
| Q3 2021 | 679.1K | $125M | +0.48% |
| Q2 2021 | 799.4K | $143M | +0.54% |
| Q1 2021 | 1.04M | $175M | +0.68% |
| Q4 2020 | 1.13M | $171M | +0.66% |
| Q3 2020 | 1.27M | $128M | +0.54% |
| Q2 2020 | 1.21M | $146M | +0.63% |
| Q1 2020 | 785.4K | $74M | +0.43% |
| Q4 2019 | 787.8K | $69M | +0.32% |
| Q3 2019 | 831.7K | $66M | +0.28% |
| Q2 2019 | 913.1K | $71M | +0.34% |
| Q1 2019 | 1.02M | $120M | +0.52% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Acadian Asset Management LLC’s full portfolio or all institutional holders of UTHR.